img

Global Oral Antidiabetic Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Antidiabetic Drugs Market Insights, Forecast to 2034

Oral antidiabetic drugs are medications used to manage blood glucose levels in individuals with type 2 diabetes. They work by improving insulin sensitivity, increasing insulin production, or reducing glucose production in the liver.
Market Analysis and InsightsGlobal Oral Antidiabetic Drugs Market
Global Oral Antidiabetic Drugs market is expected to reach to US$ 1862 million in 2024, with a positive growth of %, compared with US$ 1844 million in 2022. Backed with the increasing demand from downstream industries, Oral Antidiabetic Drugs industry is evaluated to reach US$ 2236.3 million in 2029. The CAGR will be 3.1% during 2024 to 2029.
The market for oral antidiabetic drugs is driven by the growing prevalence of type 2 diabetes and the need for effective and convenient glucose-lowering medications. The market's growth is also influenced by ongoing research in diabetes therapeutics, leading to the development of new drug classes and combination therapies.
Report Covers
This report presents an overview of global Oral Antidiabetic Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Antidiabetic Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Huadong Medicine Co.,Ltd.
Lepu Medical
Hengrui Medicine
Segment by Type
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oral Antidiabetic Drugs introduction, etc. Oral Antidiabetic Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Oral Antidiabetic Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Alpha-glucosidase inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Drugs Market Perspective (2018-2029)
2.2 Global Oral Antidiabetic Drugs Growth Trends by Region
2.2.1 Oral Antidiabetic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Antidiabetic Drugs Historic Market Size by Region (2018-2024)
2.2.3 Oral Antidiabetic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Oral Antidiabetic Drugs Market Dynamics
2.3.1 Oral Antidiabetic Drugs Industry Trends
2.3.2 Oral Antidiabetic Drugs Market Drivers
2.3.3 Oral Antidiabetic Drugs Market Challenges
2.3.4 Oral Antidiabetic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Antidiabetic Drugs by Players
3.1.1 Global Oral Antidiabetic Drugs Revenue by Players (2018-2024)
3.1.2 Global Oral Antidiabetic Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Antidiabetic Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Oral Antidiabetic Drugs Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Drugs Revenue in 2022
3.5 Global Key Players of Oral Antidiabetic Drugs Head office and Area Served
3.6 Global Key Players of Oral Antidiabetic Drugs, Product and Application
3.7 Global Key Players of Oral Antidiabetic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Drugs Breakdown Data by Type
4.1 Global Oral Antidiabetic Drugs Historic Market Size by Type (2018-2024)
4.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2024-2029)
5 Oral Antidiabetic Drugs Breakdown Data by Application
5.1 Global Oral Antidiabetic Drugs Historic Market Size by Application (2018-2024)
5.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Antidiabetic Drugs Market Size (2018-2029)
6.2 North America Oral Antidiabetic Drugs Market Size by Type
6.2.1 North America Oral Antidiabetic Drugs Market Size by Type (2018-2024)
6.2.2 North America Oral Antidiabetic Drugs Market Size by Type (2024-2029)
6.2.3 North America Oral Antidiabetic Drugs Market Share by Type (2018-2029)
6.3 North America Oral Antidiabetic Drugs Market Size by Application
6.3.1 North America Oral Antidiabetic Drugs Market Size by Application (2018-2024)
6.3.2 North America Oral Antidiabetic Drugs Market Size by Application (2024-2029)
6.3.3 North America Oral Antidiabetic Drugs Market Share by Application (2018-2029)
6.4 North America Oral Antidiabetic Drugs Market Size by Country
6.4.1 North America Oral Antidiabetic Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Oral Antidiabetic Drugs Market Size by Country (2018-2024)
6.4.3 North America Oral Antidiabetic Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oral Antidiabetic Drugs Market Size (2018-2029)
7.2 Europe Oral Antidiabetic Drugs Market Size by Type
7.2.1 Europe Oral Antidiabetic Drugs Market Size by Type (2018-2024)
7.2.2 Europe Oral Antidiabetic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Oral Antidiabetic Drugs Market Share by Type (2018-2029)
7.3 Europe Oral Antidiabetic Drugs Market Size by Application
7.3.1 Europe Oral Antidiabetic Drugs Market Size by Application (2018-2024)
7.3.2 Europe Oral Antidiabetic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Oral Antidiabetic Drugs Market Share by Application (2018-2029)
7.4 Europe Oral Antidiabetic Drugs Market Size by Country
7.4.1 Europe Oral Antidiabetic Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Oral Antidiabetic Drugs Market Size by Country (2018-2024)
7.4.3 Europe Oral Antidiabetic Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Antidiabetic Drugs Market Size (2018-2029)
8.2 China Oral Antidiabetic Drugs Market Size by Type
8.2.1 China Oral Antidiabetic Drugs Market Size by Type (2018-2024)
8.2.2 China Oral Antidiabetic Drugs Market Size by Type (2024-2029)
8.2.3 China Oral Antidiabetic Drugs Market Share by Type (2018-2029)
8.3 China Oral Antidiabetic Drugs Market Size by Application
8.3.1 China Oral Antidiabetic Drugs Market Size by Application (2018-2024)
8.3.2 China Oral Antidiabetic Drugs Market Size by Application (2024-2029)
8.3.3 China Oral Antidiabetic Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Antidiabetic Drugs Market Size (2018-2029)
9.2 Asia Oral Antidiabetic Drugs Market Size by Type
9.2.1 Asia Oral Antidiabetic Drugs Market Size by Type (2018-2024)
9.2.2 Asia Oral Antidiabetic Drugs Market Size by Type (2024-2029)
9.2.3 Asia Oral Antidiabetic Drugs Market Share by Type (2018-2029)
9.3 Asia Oral Antidiabetic Drugs Market Size by Application
9.3.1 Asia Oral Antidiabetic Drugs Market Size by Application (2018-2024)
9.3.2 Asia Oral Antidiabetic Drugs Market Size by Application (2024-2029)
9.3.3 Asia Oral Antidiabetic Drugs Market Share by Application (2018-2029)
9.4 Asia Oral Antidiabetic Drugs Market Size by Region
9.4.1 Asia Oral Antidiabetic Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Oral Antidiabetic Drugs Market Size by Region (2018-2024)
9.4.3 Asia Oral Antidiabetic Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral Antidiabetic Drugs Introduction
11.1.4 Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.1.5 Eli Lilly Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Oral Antidiabetic Drugs Introduction
11.2.4 Abbott Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.2.5 Abbott Recent Developments
11.3 Biocon
11.3.1 Biocon Company Details
11.3.2 Biocon Business Overview
11.3.3 Biocon Oral Antidiabetic Drugs Introduction
11.3.4 Biocon Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.3.5 Biocon Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic Drugs Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.4.5 Sanofi Recent Developments
11.5 Sunpharma
11.5.1 Sunpharma Company Details
11.5.2 Sunpharma Business Overview
11.5.3 Sunpharma Oral Antidiabetic Drugs Introduction
11.5.4 Sunpharma Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.5.5 Sunpharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Antidiabetic Drugs Introduction
11.6.4 Novartis Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Oral Antidiabetic Drugs Introduction
11.7.4 Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.7.5 Novo Nordisk Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Drugs Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.8.5 Merck Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Drugs Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.9.5 Pfizer Recent Developments
11.10 Huadong Medicine Co.,Ltd.
11.10.1 Huadong Medicine Co.,Ltd. Company Details
11.10.2 Huadong Medicine Co.,Ltd. Business Overview
11.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Introduction
11.10.4 Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.10.5 Huadong Medicine Co.,Ltd. Recent Developments
11.11 Lepu Medical
11.11.1 Lepu Medical Company Details
11.11.2 Lepu Medical Business Overview
11.11.3 Lepu Medical Oral Antidiabetic Drugs Introduction
11.11.4 Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.11.5 Lepu Medical Recent Developments
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Oral Antidiabetic Drugs Introduction
11.12.4 Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.12.5 Hengrui Medicine Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Antidiabetic Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Alpha-glucosidase inhibitors
Table 5. Global Oral Antidiabetic Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Oral Antidiabetic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oral Antidiabetic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Oral Antidiabetic Drugs Market Share by Region (2018-2024)
Table 9. Global Oral Antidiabetic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oral Antidiabetic Drugs Market Share by Region (2024-2029)
Table 11. Oral Antidiabetic Drugs Market Trends
Table 12. Oral Antidiabetic Drugs Market Drivers
Table 13. Oral Antidiabetic Drugs Market Challenges
Table 14. Oral Antidiabetic Drugs Market Restraints
Table 15. Global Oral Antidiabetic Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Oral Antidiabetic Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Oral Antidiabetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2022)
Table 18. Global Oral Antidiabetic Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Oral Antidiabetic Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Oral Antidiabetic Drugs, Headquarters and Area Served
Table 21. Global Key Players of Oral Antidiabetic Drugs, Product and Application
Table 22. Global Key Players of Oral Antidiabetic Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Oral Antidiabetic Drugs Revenue Share by Application (2018-2024)
Table 30. Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oral Antidiabetic Drugs Revenue Share by Application (2024-2029)
Table 32. North America Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Oral Antidiabetic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Oral Antidiabetic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Oral Antidiabetic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Oral Antidiabetic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Oral Antidiabetic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Oral Antidiabetic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Oral Antidiabetic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Oral Antidiabetic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Oral Antidiabetic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Oral Antidiabetic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Oral Antidiabetic Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Oral Antidiabetic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Oral Antidiabetic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Oral Antidiabetic Drugs Product
Table 67. Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 68. Eli Lilly Recent Developments
Table 69. Abbott Company Details
Table 70. Abbott Business Overview
Table 71. Abbott Oral Antidiabetic Drugs Product
Table 72. Abbott Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 73. Abbott Recent Developments
Table 74. Biocon Company Details
Table 75. Biocon Business Overview
Table 76. Biocon Oral Antidiabetic Drugs Product
Table 77. Biocon Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 78. Biocon Recent Developments
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Oral Antidiabetic Drugs Product
Table 82. Sanofi Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 83. Sanofi Recent Developments
Table 84. Sunpharma Company Details
Table 85. Sunpharma Business Overview
Table 86. Sunpharma Oral Antidiabetic Drugs Product
Table 87. Sunpharma Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 88. Sunpharma Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Oral Antidiabetic Drugs Product
Table 92. Novartis Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Novo Nordisk Company Details
Table 95. Novo Nordisk Business Overview
Table 96. Novo Nordisk Oral Antidiabetic Drugs Product
Table 97. Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 98. Novo Nordisk Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Oral Antidiabetic Drugs Product
Table 102. Merck Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Oral Antidiabetic Drugs Product
Table 107. Pfizer Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 108. Pfizer Recent Developments
Table 109. Huadong Medicine Co.,Ltd. Company Details
Table 110. Huadong Medicine Co.,Ltd. Business Overview
Table 111. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product
Table 112. Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 113. Huadong Medicine Co.,Ltd. Recent Developments
Table 114. Lepu Medical Company Details
Table 115. Lepu Medical Business Overview
Table 116. Lepu Medical Oral Antidiabetic Drugs Product
Table 117. Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 118. Lepu Medical Recent Developments
Table 119. Hengrui Medicine Company Details
Table 120. Hengrui Medicine Business Overview
Table 121. Hengrui Medicine Oral Antidiabetic Drugs Product
Table 122. Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 123. Hengrui Medicine Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Oral Antidiabetic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Alpha-glucosidase inhibitors Features
Figure 6. Global Oral Antidiabetic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oral Antidiabetic Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Antidiabetic Drugs Report Years Considered
Figure 12. Global Oral Antidiabetic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Oral Antidiabetic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Oral Antidiabetic Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Oral Antidiabetic Drugs Market Share by Players in 2022
Figure 16. Global Top Oral Antidiabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Oral Antidiabetic Drugs Revenue in 2022
Figure 18. North America Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Oral Antidiabetic Drugs Market Share by Type (2018-2029)
Figure 20. North America Oral Antidiabetic Drugs Market Share by Application (2018-2029)
Figure 21. North America Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 22. United States Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oral Antidiabetic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Oral Antidiabetic Drugs Market Share by Type (2018-2029)
Figure 26. Europe Oral Antidiabetic Drugs Market Share by Application (2018-2029)
Figure 27. Europe Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 28. Germany Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Oral Antidiabetic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Oral Antidiabetic Drugs Market Share by Type (2018-2029)
Figure 36. China Oral Antidiabetic Drugs Market Share by Application (2018-2029)
Figure 37. Asia Oral Antidiabetic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Oral Antidiabetic Drugs Market Share by Type (2018-2029)
Figure 39. Asia Oral Antidiabetic Drugs Market Share by Application (2018-2029)
Figure 40. Asia Oral Antidiabetic Drugs Market Share by Region (2018-2029)
Figure 41. Japan Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 51. Brazil Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 58. Abbott Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 59. Biocon Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 60. Sanofi Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 61. Sunpharma Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 62. Novartis Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 63. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 64. Merck Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 65. Pfizer Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 66. Huadong Medicine Co.,Ltd. Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 67. Lepu Medical Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 68. Hengrui Medicine Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries